Article
Risk factors of treatment failure and 30-day mortality in patients with bacteremia due to MRSA with reduced vancomycin susceptibility.
Scientific reports - 18 May 2018
Yang Chien-Chang, Sy Cheng-Len, Huang Yhu-Chering, Shie Shian-Sen, Shu Jwu-Ching, Hsieh Pang-Hsin, Hsiao Ching-Hsi, Chen Chih-Jung
Abstract excerpt
Bacteremia caused by MRSA with reduced vancomycin susceptibility (MRSA-RVS) frequently resulted in treatment failure and mortality. The relation of bacterial factors and unfavorable outcomes remains controversial. We retrospectively reviewed clinical data of patients with bacteremia caused by MRSA with vancomycin MIC = 2 mg/L from 2009 to 2012. The significance of bacterial genotypes, agr function and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
